Shahian D M, Wallach S R, Bern M M
Surg Clin North Am. 1985 Apr;65(2):315-22. doi: 10.1016/s0039-6109(16)43586-3.
The presence of cold-reactive proteins may pose special hazards to the patient about to undergo hypothermic cardiopulmonary bypass, topical myocardial cooling, and cold potassium cardioplegic arrest. The detection and characterization of such proteins, their potential adverse effects, and a proposed management protocol are discussed.
冷反应蛋白的存在可能会给即将接受低温体外循环、局部心肌降温及冷钾停搏液心脏停搏的患者带来特殊风险。本文讨论了此类蛋白的检测与特性、其潜在的不良影响以及拟议的处理方案。